The whole market has taken a dump and biotech got hit harder than other sectors. With CTSO, I just don't know. I park trading funds there because it is just a matter of when not if they succeed. I have gone back and forth on ACRX, but I am leaning toward approval at this point. However, look at TXMD, FDA approval then dropped. Had a 1.1B MC at approval, so they need to prove they can become profitable or sell out to move up. ACRX MC 235M with a potential of over 1B MC near term if approved. But then again this market is crazy right now. Nice discounts on things like CTSO.
News 
Market Data 
Discover 
